Poly(Lactide-co-glycolide) ultrasonographic microbubbles carrying Sudan black for preoperative and intraoperative localization of lymph nodes

Clin Breast Cancer. 2012 Jun;12(3):199-206. doi: 10.1016/j.clbc.2012.01.005. Epub 2012 Mar 7.

Abstract

Lymph node (LN) examination plays a critical role in the staging and treatment of several kinds of cancer such as lesions of the breast. However current strategies have limitations. This study aimed to develop a novel imaging agent, a polymeric ultrasonographic contrast agent carrying Sudan black (SB), for ultrasonographic imaging of the regional LNs before surgery and to directly localize the LNs during surgery. The poly(lactide-co-glycolide) (PLGA) ultrasonographic microbubbles carrying Sudan black B (SB) (SB-PLGA microbubbles) were prepared by the double emulsion method. The SB-PLGA microbubbles had a diameter of 1.5 ± 0.5 μm and the SB encapsulation efficiency was (86.2 ± 1.56%). Results from MTT assays suggested that these bubbles have little cytotoxicity to mouse macrophages after incubation. Confocal laser scanning microscopy showed that the PLGA microbubbles carrying the fluorescent dye rhodamine 6G were taken up by macrophages after 2-hour incubation. In addition, these SB-PLGA microbubbles were able to enhance ultrasonographic contrast of 12 popliteal LNs of 6 rabbits. Furthermore, the LNs were easily identifiable by the naked eye during surgery because of the blue color of the SB-PLGA microbubbles inside the LNs. By cryosectioning and hematoxylin and eosin (H&E) staining of LN tissue, our results showed that these SB-PLGA microbubbles were internalized inside the macrophages of the LNs. To conclude, the SB-PLGA microbubbles could be a suitable imaging agent for preoperative and intraoperative localization of LNs as well as for a preoperative ultrasonographically guided core needle biopsy of suspicious sentinel lymph nodes (SLNs) in cancer patients, hence enhancing treatment outcome.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Azo Compounds / administration & dosage*
  • Azo Compounds / adverse effects
  • Azo Compounds / chemistry
  • Azo Compounds / pharmacokinetics
  • Cells, Cultured
  • Contrast Media / administration & dosage
  • Contrast Media / adverse effects
  • Contrast Media / chemistry
  • Contrast Media / pharmacokinetics
  • Drug Carriers
  • Intraoperative Period
  • Lactic Acid / administration & dosage*
  • Lactic Acid / adverse effects
  • Lactic Acid / chemistry
  • Lactic Acid / pharmacokinetics
  • Lymph Nodes / drug effects
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis / diagnostic imaging
  • Lymphatic Metastasis / pathology
  • Mice
  • Microbubbles
  • Naphthalenes
  • Polyglycolic Acid / administration & dosage*
  • Polyglycolic Acid / adverse effects
  • Polyglycolic Acid / chemistry
  • Polyglycolic Acid / pharmacokinetics
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Preoperative Period
  • Rabbits
  • Sentinel Lymph Node Biopsy / instrumentation
  • Sentinel Lymph Node Biopsy / methods*
  • Ultrasonography, Interventional / instrumentation
  • Ultrasonography, Interventional / methods

Substances

  • Azo Compounds
  • Contrast Media
  • Drug Carriers
  • Naphthalenes
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Sudan Black B